170 related articles for article (PubMed ID: 10862469)
1. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
[TBL] [Abstract][Full Text] [Related]
2. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
Makolkin VI; Vakhliaev VD
Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
[TBL] [Abstract][Full Text] [Related]
3. [The role of metabolic correction in the combined therapy of middle-aged and elderly patients with ischemic heart disease].
Kraĭdashenko OV; Berezin AE; Molodan AV
Lik Sprava; 1996; (10-12):114-6. PubMed ID: 9138782
[No Abstract] [Full Text] [Related]
4. [An amino acid metabolic complex in optimizing the cardiac hemodynamic characteristics of patients with ischemic heart disease].
Berezin AE; Fushteĭ IM; Kraĭdashenko OV
Lik Sprava; 1998 Dec; (8):94-6. PubMed ID: 10204359
[TBL] [Abstract][Full Text] [Related]
5. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
[TBL] [Abstract][Full Text] [Related]
6. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
Dunaev VV; Kraĭdashenko OV; Berezin AE
Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
[TBL] [Abstract][Full Text] [Related]
7. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
[No Abstract] [Full Text] [Related]
8. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
[TBL] [Abstract][Full Text] [Related]
9. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
[TBL] [Abstract][Full Text] [Related]
10. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
Lizogub VG; Chumak AA; Savchenko AV; Pliskevich DA
Lik Sprava; 2000; (3-4):31-4. PubMed ID: 10921255
[TBL] [Abstract][Full Text] [Related]
11. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
Zakirova AN
Ter Arkh; 1995; 67(4):33-5. PubMed ID: 7784970
[TBL] [Abstract][Full Text] [Related]
12. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
Mitra B; Panja M
J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
[TBL] [Abstract][Full Text] [Related]
13. [Psychophysiological approaches to assessing patients with painful and painless forms of ischemic heart disease].
Lipovetskii BM; Reznikova TN; Il'ina GN; Petukhova NV; Stoianov AM
Ter Arkh; 1995; 67(12):8-11. PubMed ID: 8820044
[TBL] [Abstract][Full Text] [Related]
14. [Results of long-term administration of propranolol to patients with ischemic heart disease].
Bychko MV
Lik Sprava; 2003; (5-6):93-5. PubMed ID: 14618816
[TBL] [Abstract][Full Text] [Related]
15. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
[No Abstract] [Full Text] [Related]
16. [Pelotherapy in ischemic heart disease].
Davydova OB; Nikolaeva LF; Nagiev IuK
Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (1):2-6. PubMed ID: 8171844
[TBL] [Abstract][Full Text] [Related]
17. [Angina pectoris. Silent ischemia].
Tuna JL
Acta Med Port; 1997 Apr; 10(4):267-75. PubMed ID: 9341023
[TBL] [Abstract][Full Text] [Related]
18. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
Skibitskiĭ VV
Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
[No Abstract] [Full Text] [Related]
19. [The preoperative drug correction of disorders in myocardial functional reserve in patients with ischemic heart disease].
Molodan AV; Salgalov AV; Osaulenko VV; Materukhin AN
Klin Khir (1962); 1994; (5):29-31. PubMed ID: 7807893
[TBL] [Abstract][Full Text] [Related]
20. Anti-anginal effects of partial fatty acid oxidation inhibitors.
Lam A; Lopaschuk GD
Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
